Mivacurium infusion requirements following vecuronium: different response between adults and children
- PMID: 7553995
- DOI: 10.1007/BF03011876
Mivacurium infusion requirements following vecuronium: different response between adults and children
Abstract
The mivacurium infusion requirements following vecuronium were evaluated in 15 adults and 15 children in an open prospective clinical study. This study was undertaken to elucidate whether potentiation of effect occurred when a mivacurium infusion was administered after vecuronium was used for the facilitation of tracheal intubation. The adult patients were anaesthetized with N2O:02, propofol and fentanyl, the children with halothane (1%) N2O:O2. Vecuronium 100 micrograms.kg-1 was administered during stimulation of the ulnar nerve with train-of-four stimuli at 0.1 Hz. The force of contraction of adductor pollicis was recorded. Upon recovery of the twitch response from vecuronium, a mivacurium infusion was started at 4 micrograms.kg-1.min-1, thereafter adjustments were made to maintain the first twitch of the train-of-four (T1) at 1-10% of control. The mean (+/- SE) initial infusion requirements in children of mivacurium was 4.3 (0.4) micrograms.kg-1.min-1 which increased linearly (P < 0.001) over the next 90 min to 10 micrograms.kg-1.min-1. In adults the infusion requirement was lower than in children and remained at approximately 3 micrograms.kg-1.min-1 over the next 75 min. At the end of the surgical procedure, the children recovered faster than the adults with no child requiring reversal. Because of prolonged recovery ( > 20 min), seven adults required reversal with 15-70 micrograms.kg-1 neostigmine. Mivacurium infusion requirements following vecuronium are higher in children than adults. Potentiation of the effects of mivacurium were seen when vecuronium preceded mivacurium. This potentiation of effect lasted longer in adults than in children.
Similar articles
-
The duration of action of mivacurium is prolonged if preceded by atracurium or vecuronium.Acta Anaesthesiol Scand. 1995 Oct;39(7):912-5. doi: 10.1111/j.1399-6576.1995.tb04197.x. Acta Anaesthesiol Scand. 1995. PMID: 8848891 Clinical Trial.
-
A comparison of the neuromuscular blocking effects of atracurium, mivacurium, and vecuronium on the adductor pollicis and the orbicularis oculi muscle in humans.Anesth Analg. 1996 Oct;83(4):808-13. doi: 10.1097/00000539-199610000-00027. Anesth Analg. 1996. PMID: 8831326 Clinical Trial.
-
Interactions between mivacurium, rocuronium, and vecuronium during general anesthesia.Anesth Analg. 1996 Oct;83(4):818-22. doi: 10.1097/00000539-199610000-00029. Anesth Analg. 1996. PMID: 8831328 Clinical Trial.
-
Mivacurium chloride--a comparative profile.Acta Anaesthesiol Scand Suppl. 1995;106:23-5. doi: 10.1111/j.1399-6576.1995.tb04304.x. Acta Anaesthesiol Scand Suppl. 1995. PMID: 8533540 Review.
-
Mivacurium in infants and children.Paediatr Anaesth. 1997;7(3):183-90. Paediatr Anaesth. 1997. PMID: 9189962 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous